價(jià)格 | ¥15300 | ¥19500 | ¥11700 |
包裝 | 50mg | 100mg | 25mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 Guadecitabine sodium | 英文名稱:Guadecitabine sodium |
CAS:929904-85-8 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號(hào): T12790 |
名稱 | Guadecitabine sodium |
描述 | Guadecitabine sodium is a inhibitor of second-generation DNA methyltransferases (DNMT) . |
體外活性 | HCT116 colorectal carcinoma cells are treated After 6 days, in p16expression is observed with Guadecitabine sodium (SGI-110 sodium) show a dose-dependent increase . In addition, a dose-dependent increase in the level of p16 protein in T24 and HCT116 cells treated with Guadecitabine sodium or 5-aza-CdR for 3 days, showing the competence of Guadecitabine sodium to inhibit DNA methylation and induce p16 at both mRNA and protein levels as well as 5-aza-CdR. Thus, Guadecitabine sodium is able to inhibit DNA methylation at 5′-region and induce the expression of the p16 gene in T24 and HCT116 cells at concentrations comparable to 5-aza-CdR, and the induction of p16 expression by both agents correlates with the demethylation at the 5′-end region of the gene in both cell lines. Guadecitabine sodium is slightly less toxic than 5-aza-CdR at the doses tested up to 1 μM concentration but displaying similar toxicity at 10 μM concentration[1]. |
體內(nèi)活性 | Guadecitabine sodium(10mg/kg )is an effective dose at reducing DNA methylation and retarding tumor growth, and caused roughly the same level of toxicity as 5-Aza-CdR. Guadecitabine sodium is effective in vivo at reactivating the expression of the p16 gene, which is heavily methylated in the parent EJ6 cells. Guadecitabine sodium is effective in reducing the level of DNA methylation in vivo at the p16 promoter region. Guadecitabine sodium is better tolerated than 5-Aza-CdR in vivo[2]. |
存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (86.30 mM), Sonication is recommended. H2O : Soluble |
關(guān)鍵字 | Guadecitabine sodium |
相關(guān)產(chǎn)品 | Zebularine | Dihydro-5-azacytidine FA | TFMB-(S)-2-HG | 6-Thioguanine | GSK-3484862 | Levetiracetam | 5-Azacytidine | 5-Methyl-2'-deoxycytidine | Hinokitiol | Procainamide hydrochloride | γ-Oryzanol | SW155246 |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬(wàn)人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP5年
|
河南威梯?;た萍加邢薰?/div>
|
2024-12-27 | |
詢價(jià) |
VIP3年
|
陜西締都新材料有限公司
|
2024-12-18 | |
詢價(jià) |
VIP1年
|
青島愷潤(rùn)生物醫(yī)藥科技有限公司
|
2024-11-02 | |
詢價(jià) |
VIP6年
|
成都彼樣生物科技有限公司
|
2024-12-19 |